Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained Strong at 12.3%
Akums Drugs and Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization…
Asia Pacifics Demand for IT and Business Services Slows in Q2, ISG Index Shows
Despite 16% growth in cloud ACV, the combined market was down slightly…
